Barla Thomas
Nurse Practitioner · Henagar, ALNPI 1568600617
Payments from drug & device makers
Across 218 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$675
- AbbVie$548
- GSK$350
- Lilly USA, LLC$222
- Takeda Pharmaceuticals U.S.A., Inc.$164
- Bayer$151
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,624100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 48 | $675 |
| AbbVie | 34 | $548 |
| GSK | 22 | $350 |
| Lilly USA, LLC | 12 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $164 |
| Bayer | 8 | $151 |
| Novartis | 7 | $122 |
| Dexcom, Inc. | 6 | $118 |
| Mylan Specialty L.p. | 6 | $115 |
| Sanofi-aventis U.S. LLC | 7 | $94 |
| Pfizer | 5 | $86 |
| Abbott | 4 | $76 |
| Scilex Pharmaceuticals Inc. | 4 | $75 |
| AstraZeneca | 5 | $74 |
| Corcept Therapeutics | 3 | $71 |
| Merck | 4 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $61 |
| Exact Sciences | 4 | $61 |
| Boehringer Ingelheim | 3 | $51 |
| Medtronic | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Indivior Inc. | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 3 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $39 |
| Biohaven Pharmaceuticals, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $23 |
| Almatica Pharma LLC | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$3,624 in reported general payments places this provider in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 51 | $59,713 |
| OzempicSemaglutide | 45 | $50,081 |
| JardianceEmpagliflozin | 21 | $19,670 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $12,857 |
| FarxigaDapagliflozin Propanediol | 18 | $12,036 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,542 |
| EntrestoSacubitril/Valsartan | 22 | $7,892 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $6,463 |
| JanuviaSitagliptin Phosphate | 11 | $5,696 |
| Celecoxib | 25 | $3,072 |
| Levothyroxine Sodium | 71 | $1,414 |
| Montelukast Sodium | 59 | $927 |
| Fluticasone Propionate | 49 | $801 |
| Pantoprazole Sodium | 75 | $697 |
| Atorvastatin Calcium | 38 | $691 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $222 | $59,71351 claims |
| Novo NordiskOzempic | $675 | $50,08145 claims |
| Boehringer IngelheimJardiance | $51 | $19,67021 claims |
| AstraZenecaFarxiga | $74 | $12,03618 claims |
| GSKTrelegy Ellipta | $350 | $8,54213 claims |
| NovartisEntresto | $122 | $7,89222 claims |
| MerckJanuvia | $69 | $5,69611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Henagar
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$126K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
- Ashley HodgensMontgomery$19K
- Lisa PeoplesBirmingham$17K
- Samantha WeaverBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.